Title : Angiogenesis in JAK2 V617F positive myeloproliferative neoplasms and ruxolitinib decrease VEGF, HIF-1 enesis in JAK2 V617F positive cells.

Pub. Date : 2018 Jan

PMID : 28554272






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ruxolitinib, a JAK inhibitor, is an effective treatment for some MPNs. ruxolitinib Janus kinase 3 Gallus gallus